Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1336, 2002-01, pp. : 6-6
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Access to resources
Recommend
Peripheral Arterial Obliterative Disease: Cost of Illness in France
By Montron A.
PharmacoEconomics, Vol. 13, Iss. 1 Part 2, 1998-01 ,pp. :
Abciximab for high-risk patients: effective at a cost
Inpharma, Vol. 1, Iss. 1262, 2000-01 ,pp. :
Abciximab for high-risk patients: effective at a cost
PharmacoEconomics and Outcomes News, Vol. 1, Iss. 287, 2000-01 ,pp. :
Cost Effectiveness of Abciximab During Routine Medical Practice
By Reed S.O.
PharmacoEconomics, Vol. 18, Iss. 3, 2000-09 ,pp. :